Related Experiment Video

Updated: Jun 10, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Adenovirus-based therapy for prostate cancer

Maria Ekblad1, Gunnel Halldén

  • 1Queen Mary University of London, John Vane Science Centre, Centre for Molecular Oncology and Imaging, Barts and the London School of Medicine and Dentistry, Charterhouse Square, London, EC1M 6BQ, UK.

Current Opinion in Molecular Therapeutics
|August 3, 2010
PubMed

Insights

Virotherapy shows promise for treating prostate cancer, a leading cause of male cancer deaths. This approach uses oncolytic viruses, like adenoviral mutants, with minimal toxicity for effective cancer treatment.

Area of Science:

  • Oncology
  • Virology
  • Biomedical Engineering

Background:

  • Prostate cancer remains a significant cause of cancer-related mortality in men.
  • Current treatments face challenges in efficacy and toxicity.
  • Virotherapy offers a novel, targeted approach to cancer treatment.

Purpose of the Study:

  • To review advancements in virotherapy for prostate cancer.
  • To highlight the potential of replication-selective adenoviral mutants.
  • To discuss virotherapy as a multimodal therapeutic strategy.

Main Methods:

  • Focus on replication-selective oncolytic viruses, particularly adenoviral mutants.
  • Review of preclinical studies in cell lines and in vivo models.
  • Analysis of early-stage clinical trial data for prostate cancer.

Main Results:

  • Virotherapy demonstrates potent and selective antitumor activity.
  • Oncolytic viruses show minimal toxicity to normal cells.
  • Early trials indicate potential efficacy in hormone-refractory prostate cancer.

Conclusions:

  • Virotherapy, especially with adenoviral mutants, is a promising strategy for prostate cancer.
  • Combination therapies enhance the efficacy of virotherapy.
  • Further research and clinical trials are warranted to optimize treatment outcomes.

More Related Videos

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...